India’s pharmaceutical exports have demonstrated resilience amid global economic challenges, approaching the $29 billion mark by February of this financial year. This robust performance highlights the sector’s strength in the face of considerable market volatility.
The surge in exports is primarily driven by formulations, biologicals, vaccines, and Ayush products. These categories have shown significant growth, reinforcing India’s position as a key global supplier.
Looking ahead, the Indian pharmaceutical sector is anticipated to experience substantial expansion by 2030. This growth trajectory underscores India’s increasing importance in the international pharmaceutical landscape.
India continues to be a vital source of affordable medicines, ensuring access to essential healthcare products worldwide. The country’s pharmaceutical industry plays a crucial role in meeting global healthcare needs.
About the Author
